Inappropriate antimicrobial prescribing contributes to antibiotic resistance, a significant public health concern. Recent evaluations of cephalosporin prescribing practices in tertiary care settings highlight areas for improved adherence to antimicrobial stewardship principles, particularly regarding de-escalation and drug-drug interactions.
Antimicrobial resistance poses a substantial threat to public health, necessitating rigorous antimicrobial stewardship programs.3 Cephalosporins, a widely used class of antibiotics, are frequently prescribed for various infectious diseases. Understanding prescribing patterns, adherence to guidelines, and associated challenges is critical for effective stewardship. Studies from South India and South Africa provide insights into these practices within tertiary care hospitals.1,2
Evaluation of Prescribing Practices
A prospective evaluation in a tertiary care hospital in South India assessed cephalosporin prescribing patterns in adult inpatients. The study focused on clinical appropriateness, susceptibility and resistance profiles, potential drug-drug interactions, and de-escalation practices in infectious disease management.1 Similarly, a study at a South African tertiary referral hospital utilized three global point prevalence surveys to examine antimicrobial prescribing patterns, including cephalosporins. This research also aimed to assess clinical appropriateness, susceptibility and resistance profiles, potential drug-drug interactions, and de-escalation practices.2
Both studies aimed to identify areas where prescribing practices deviated from established guidelines. Key aspects under scrutiny included the initial choice of cephalosporin, the rationale for its use, and the subsequent management, such as dose adjustments and de-escalation strategies. The South Indian study, for instance, provided a detailed look into the local context of prescribing.1 The South African study offered a broader perspective by incorporating data from multiple point prevalence surveys, allowing for comparative analysis over time.2
Key Findings and Limitations
The studies identified variations in adherence to antimicrobial stewardship guidelines. While specific quantitative data on adherence rates, such as percentages of appropriate prescriptions or rates of de-escalation, were not detailed in the abstracts, the stated objectives indicate that these areas were points of investigation. Both studies aimed to characterize susceptibility and resistance profiles, which are fundamental for guiding appropriate empiric and definitive therapy. The presence of potential drug-drug interactions was also a focus, highlighting the complexity of managing polypharmacy in hospitalized patients.1,2
A common thread across these evaluations was the emphasis on de-escalation practices. De-escalation, the process of narrowing the spectrum of antimicrobial therapy once culture and susceptibility results are available, is a cornerstone of effective antimicrobial stewardship. The studies sought to understand how frequently and effectively de-escalation was implemented.1,2 The abstracts, however, do not provide specific data on the prevalence of inappropriate prescribing or the impact of identified drug-drug interactions. The lack of detailed numerical outcomes in the abstracts limits a comprehensive understanding of the extent of the issues identified. Future publications from these studies should provide the specific rates and statistical analyses to fully inform clinical practice.
The consistent focus on cephalosporin prescribing patterns, de-escalation, and drug-drug interactions across these studies underscores a persistent challenge in antimicrobial stewardship. Clinicians, particularly those in tertiary care, must recognize that the initial choice of antibiotic is only one facet of responsible prescribing. The ongoing assessment for de-escalation opportunities, guided by local antibiograms and patient response, is equally critical. Failure to de-escalate contributes directly to the selective pressure driving resistance, an outcome that disproportionately affects vulnerable patient populations.
Pharmaceutical companies developing new antimicrobial agents face an environment where the efficacy of existing drugs is continually eroded by resistance. These studies, while not directly evaluating new compounds, highlight the urgent need for novel agents that address resistant pathogens, alongside robust stewardship programs to preserve their utility. The industry's role extends beyond discovery to supporting educational initiatives that reinforce judicious prescribing practices among healthcare providers. Without this dual approach, the pipeline of new drugs will merely delay, rather than solve, the problem of antimicrobial resistance.
For patients, the implications of suboptimal antimicrobial stewardship are severe. Prolonged broad-spectrum antibiotic use increases the risk of adverse drug reactions, including Clostridioides difficile infection, and contributes to the development of multidrug-resistant infections that are harder to treat. These studies serve as a reminder that every prescription has broader consequences, impacting not only the individual patient's immediate outcome but also the collective efficacy of antibiotics for future generations. Adherence to guidelines is not merely bureaucratic compliance, it is a direct determinant of patient safety and public health.
- The Pivot Cephalosporin prescribing patterns vary, with specific challenges in guideline adherence for de-escalation and managing drug-drug interactions.
- The Data Specific adherence rates and resistance profiles were not uniformly reported across studies, indicating a need for more granular data.
- The Action Clinicians should prioritize regular review of local susceptibility data and enhance vigilance for potential drug-drug interactions and de-escalation opportunities.
ART-2026-168
Cite This Article
Team TLSFE. Antimicrobial stewardship: cephalosporin prescribing patterns assessed. The Life Science Feed. Updated May 31, 2026. Accessed May 31, 2026. https://thelifesciencefeed.com/infectious-diseases/drug-resistance-microbial/practice/antimicrobial-stewardship-cephalosporin-prescribing-patterns-assessed.
Licence & Rights
© 2026 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.
Editorial & AI Standards
All content is researched from peer-reviewed, open-access sources — published trial data, clinical guidelines, and regulatory filings. AI tools are used solely to structure and summarise that evidence; no AI-generated conclusions appear without editor verification against the primary source.
Every article is reviewed by a named editor before publication. Source citations are listed in the References section. This content does not represent the views of any pharmaceutical company, medical device manufacturer, or healthcare provider.
References
1. Pavithra K, Shajan RS, Parvis AM. Prospective Evaluation of Cephalosporin Prescribing and Guideline Adherence in Adult Inpatients at a Tertiary Care Hospital in South India. J Res Pharm Pract 2026.
2. Sher L, Pillay-Fuentes Lorente V, Taljaard J. Antimicrobial prescribing patterns at a South African tertiary referral hospital: Insights from three global point prevalence surveys. Epidemiol Infect 2026.
3. Nimmana BK, Nguyen AD. Antibiotic Resistance. 2026.
